Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf Rafflenbeul

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
MMW Fortschritte Der Medizin|November 24, 2005
[Homocysteine--risk factor or risk indicator?]Wolf Rafflenbeul
Atherosclerosis|July 11, 2006
Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemiaRenke Maas, Kurt Quitzau, Edzard Schwedhelm, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
MMW Fortschritte Der Medizin|November 24, 2005
[Homocysteine--risk factor or risk indicator?]Wolf Rafflenbeul
Atherosclerosis|July 11, 2006
Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemiaRenke Maas, Kurt Quitzau, Edzard Schwedhelm, et al.
Pageof 1